ARCHIVES

Unclear Whether Clinical Trials Benefit Patients, Review Finds

This article is from The Cancer Letter archive.

Vol. 27 No. 2 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

NCI May Ask Grantees To Assume Additional Services, Broder Says

November 11, 1994

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

December 26, 2014

Fewer Young Scientists win NIH Grants, Study

September 30, 1994

In Brief: Christopher Walsh Named Dana-Farber President; Sachs Leaves NCI; Acoustic Neuroma Conference

August 16, 1991

Medenica Trial Begins In South Carolina

February 10, 1995

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011